• David A Nielsen and Mary Jeanne Kreek.
• Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
• Drug Alcohol Depend. 2012 Jun 1; 123 Suppl 1: S33-41.

BackgroundOpioid addiction, whether to opiates such as heroin and morphine, and/or to non-medical use of opioids, is a major problem worldwide. Although drug-induced and environmental factors are essential for the liability to develop opioid addiction, the genetic background of an individual is now known also to play a substantial role.MethodsThe overall goal of this article is to address the common and specific liabilities to addiction in the context of approaches to studies of one addiction, opioid addiction. Literature on identifying genetic variants that may play a role in the development of opioid addiction was reviewed.ResultsA substantial number of genetic variants have been reported to be associated with opioid addiction. No single variant has been found in any of the reported GWAS studies with a substantial effect size on the liability to develop heroin addiction. It appears that there is a complex interaction of a large number of variants, some rare, some common, which interact with the environment and in response to specific drugs of abuse to increase the liability of developing opioid addiction.ConclusionsIn spite of the inherent difficulties in obtaining large well-phenotyped cohorts for genetic studies, new findings have been reported that are being used to develop testable hypotheses into the biological basis of opioid addiction.Copyright © 2012. Published by Elsevier Ireland Ltd.

15 keywords...

hide…